)
Zoetis (ZTS) investor relations material
Zoetis Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.R&D efficiency and innovation engine
R&D efficiency is driven by starting in target species, leading to faster and cheaper development compared to human health.
Integration of AI, genetics, diagnostics, and biomarker data accelerates target identification and molecule discovery.
Confidence in the pipeline is high for the next three to four years due to these efficiencies.
Pipeline updates and product launches
Pipeline includes 12 blockbuster products, each expected to generate at least $100 million.
Major product launches are planned annually for the next four years, including long-acting Cytopoint (2026), CKD therapeutics (2027), and oncology products (2028–2030).
CKD and oncology addressable markets exceed $5 billion combined.
CKD therapeutics target a $3–4 billion market with significant unmet needs for dogs and cats; first launch expected in 2027.
Librela performance and strategy
Librela is stabilizing in the U.S. with expectations to return to growth in the second half of 2026.
Multi-pronged strategy includes education, engagement, sharing positive case studies, and phase four studies to support growth.
Over 75% of pet owners report high satisfaction with Librela.
Librela approvals in the EU and Canada are expected to expand the market by offering more convenience and flexibility.
Next Zoetis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Animal Healthcare Giant
Zoetis Inc. is an American drug manufacturer that produces and sells medicine, medications, and vaccinations for both pets and livestock. The company is one of the largest in the industry, and its product range includes treatments for a variety of animal health issues, from common ailments in domestic pets to disease prevention in livestock. Zoetis is active in over 100 countries worldwide and has a dominating presence in the American animal health sector. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NYSE.
Pfizer Spin-off
Zoetis was founded in 1952 as a subsidiary of Pfizer and marked the beginning of the pharmaceutical company’s agricultural division. Over the years, the division evolved, focusing on the development and marketing of vaccines, medicines, and other products for animals. The division grew to become one of the largest players in the industry, and its parent company decided it was best to go separate ways from the company, for Pfizer to focus on its business while allowing Zoetis to continue with what it did best. Said and done, and in 2013 Pfizer spun off the division and Zoetis became its own company. Today, it competes against names such as Elanco and Virbac in the animal health industry.
For All Animals
The company’s portfolio includes vaccines, medicines, diagnostics, and genetic tests, catering to both livestock and companion animals. These products aim to prevent, treat, and control diseases, ensuring owners can provide the best possible healthcare possible for their animals. In the livestock sector, Zoetis provides medications and vaccines for cattle, swine, poultry, and sheep, with its products focusing on ensuring that the animals are healthy and productive. For companion animals, Zoetis offers vaccines, dermatology products, anti-infectives, and products for pain and management.
For Veterinarians
Zoetis provides a comprehensive range of products and services specifically designed for veterinarians. Beyond pharmaceuticals, which are prescribed and oftentimes administered by veterinarians, Zoetis offers diagnostic tools and tests. Moreover, Zoetis provides digital tools such as practice management software, helping veterinarians keep track of their operations and journals.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage